U.S. Court of Appeals for the Federal Circuit
Nuvo Pharm. (Ireland) Designated Activity Co. v. Dr. Reddy's Labs. Inc.
This writing
- Type
- Opinion
- Filed
- May 15, 2019
- Case
- Nuvo Pharm. (Ireland) Designated Activity Co. v. Dr. Reddy's Labs. Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Clevenger, Circuit Judge. Dr. Reddy's Laboratories, Inc., Mylan Pharmaceuticals, and Lupin Pharmaceuticals (collectively, "the Generics") appeal from the final judgment of the United States District Court for the District of New Jersey following a bench trial upholding the asserted claims of U.S. Patent Nos. 6,926,907 ("the '907 patent") and 8,557,285 ("the '285 patent") as nonobvious…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.